Insmed INSM
NASDAQ INSM
$111.12 +2.53 (+2.33%)
At close: Oct 2, 2026 · 4:00 PM EDT

Insmed (INSM) Selling, General & Administrative (2010 - 2026)

Updated

Insmed's Selling, General & Administrative came in at $247.47 million for Q2 2026, up 59.9% from $154.76 million a year earlier and up 0.1% from the prior quarter.

Analysis

Insmed (INSM) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Insmed reported Selling, General & Administrative of $893.59 million, up 58.5% year-over-year; for FY2025, it came in at $701.17 million, up 52.1% from FY2024.

  • Selling, General & Administrative has increased in each of the last five years, with a five-year compound annual growth rate of 28.1% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $461.12 million in FY2024 (+33.9%), $344.5 million in FY2023 (+29.6%), $265.78 million in FY2022 (+13.5%) and $234.27 million in FY2021 (+15.1%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
  • Year-over-year, Selling, General & Administrative has increased for 23 consecutive quarters, with growth averaging 53.4% over the last eight quarters.
  • The year-over-year growth in Selling, General & Administrative has ranged between 4.9% (Q2 2022) and 67.6% (Q1 2026) over the last five years.
  • Business Quant data shows INSM's Selling, General & Administrative at $247.26 million (Q1 2026), $212.48 million (Q4 2025) and $186.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Insmed 24.26 Bn 18.76 Bn 358.27 Mn 247.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 247.47 Mn
Mar 31, 2026 247.26 Mn
Dec 31, 2025 212.48 Mn
Sep 30, 2025 186.38 Mn
Jun 30, 2025 154.76 Mn
Mar 31, 2025 147.55 Mn
Dec 31, 2024 142.52 Mn
Sep 30, 2024 118.93 Mn
Jun 30, 2024 106.57 Mn
Mar 31, 2024 93.10 Mn
Dec 31, 2023 89.53 Mn
Sep 30, 2023 90.63 Mn
Jun 30, 2023 84.43 Mn
Mar 31, 2023 79.91 Mn
Dec 31, 2022 73.48 Mn
Sep 30, 2022 75.58 Mn
Jun 30, 2022 59.97 Mn
Mar 31, 2022 56.75 Mn
Dec 31, 2021 65.27 Mn
Sep 30, 2021 60.28 Mn
API Access

Insmed Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INSM&period=max&api_key=YOUR_API_KEY